Our group develops innovative vaccines against antimicrobial resistant bacterial pathogens in cooperation with a Swiss biotech company. We intend to use recombinant E. coli to produce a multivalent vaccine using a revolutionary platform approach. For the novel platform, genetically modified E. coli strains have to be established, and different vaccine products are produced and characterized. The immune protection of the different vaccine products will be tested in collaboration with our Australian University partner in preclinical models. In addition, cellular assay will be used to investigate on immune activation pathways for optimal mode of action of the vaccines. We are looking for you to work in this interdisciplinary, fascinating, and application-oriented project.
The position is initially limited until 31 December 2023.
PhD or MSc degree in microbiology, molecular biology, biochemistry or a related discipline
preferably experience in bacterial genome engineering and immunology
excellent verbal and written communication skills in English
proactive team player; eager and curious personality
Your prospects: The FHNW School of Life Sciences offers state-of-the-art technical, laboratory and office facilities. Contributing to the school’s highly motivating working environment – which is second to none – are its collaboration with a large number of companies and institutions in Switzerland and abroad, a widely varied programme of scientific events, and daily contact with young students in research and teaching. The FHNW is also committed to equal opportunities and the compatibility of private and professional life.
Contact and Address
Hochschule für Life Sciences FHNW Hofackerstrasse 30 4132Muttenz
About the position: Prof. Dr. Georg Lipps, , Contact: +41 61 228 54 52
About the recruiting process: Désirée Zoller, HR Manager, Contact: +41 61 228 57 28
Will you soon belong to our team? We look forward to your application before 1st November.